Most a short while ago, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in comparable regions as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors,